Publication | Closed Access
In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation
63
Citations
27
References
2005
Year
We conclude that in vivo alemtuzumab enables haploidentical hematopoietic stem-cell transplantation without ex vivo graft manipulation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1